FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development

Analyzing organoids and murine and human pancreatic specimens, scientists found that the receptor tyrosine kinase FGFR2 was progressively up-regulated in mutant KRAS-driven metaplasia, pre-cancerous lesions and classical PDAC.